These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1780171)

  • 1. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity.
    Butterworth AE; Sturrock RF; Ouma JH; Mbugua GG; Fulford AJ; Kariuki HC; Koech D
    Parasitology; 1991 Dec; 103 Pt 3():339-55. PubMed ID: 1780171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 13-year follow-up of treatment and snail control in an area endemic for Schistosoma mansoni in Brazil: incidence of infection and reinfection.
    de Lima e Costa MF; Rocha RS; Coura Filho P; Katz N
    Bull World Health Organ; 1993; 71(2):197-205. PubMed ID: 8490983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
    Thiong'o FW; Mbugua GG; Ouma JH; Sturrock RK
    East Afr Med J; 2002 Jan; 79(1):29-33. PubMed ID: 12380867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.
    Sturrock RF; Bensted-Smith R; Butterworth AE; Dalton PR; Kariuki HC; Koech D; Mugambi M; Ouma JH; arap Siongok TK
    Trans R Soc Trop Med Hyg; 1987; 81(2):303-14. PubMed ID: 3113005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
    Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
    Beck L; Favre TC; Pieri OS; Zani LC; Domas GG; Barbosa CS
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():165-7. PubMed ID: 11586444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.
    Butterworth AE; Dalton PR; Dunne DW; Mugambi M; Ouma JH; Richardson BA; Siongok TK; Sturrock RF
    Trans R Soc Trop Med Hyg; 1984; 78(1):108-23. PubMed ID: 6710563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
    Frenzel K; Grigull L; Odongo-Aginya E; Ndugwa CM; Loroni-Lakwo T; Schweigmann U; Vester U; Spannbrucker N; Doehring E
    Am J Trop Med Hyg; 1999 Jun; 60(6):927-31. PubMed ID: 10403322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos District, Kenya.
    Fulford AJ; Mbugua GG; Ouma JH; Kariuki HC; Sturrock RF; Butterworth AE
    Trans R Soc Trop Med Hyg; 1991; 85(4):481-8. PubMed ID: 1755056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
    Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni infection and related knowledge among schoolchildren in an endemic area of Minas Gerais, Brazil, prior to educational actions.
    Cabello RKSAA; Beck LCNH; Massara CL; Murta FLG; Guimarães RJPS; Pieri OS; Schall VT; Favre TC
    Acta Trop; 2016 Dec; 164():208-215. PubMed ID: 27647573
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sircar AD; Mwinzi PNM; Onkanga IO; Wiegand RE; Montgomery SP; Secor WE
    Am J Trop Med Hyg; 2018 Aug; 99(2):362-369. PubMed ID: 29893197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study.
    Okoyo C; Simiyu E; Njenga SM; Mwandawiro C
    BMC Public Health; 2018 Apr; 18(1):478. PubMed ID: 29642875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry.
    Sturrock RF; Klumpp RK; Ouma JH; Butterworth AE; Fulford AJ; Kariuki HC; Thiongo FW; Koech D
    Parasitology; 1994 Nov; 109 ( Pt 4)():443-53. PubMed ID: 7800412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
    Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.